Author

Steve A. Williams

SomaLogic (United States)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genetics· 1 Genomics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:gene regulatory network inference· 2 Organism:human· 2 Assay:proteomics· 2 Approach:statistical model· 2

Frequent Co-Authors

Aroon Dinesh HingoraniiD· 2 shared Claudia LangenbergiD· 2 shared Eleanor WheeleriD· 2 shared Erin OertoniD· 2 shared Jian’an LuaniD· 2 shared Julia Carrasco-ZaniniiD· 2 shared Maik PietzneriD· 2 shared Nicholas J. WarehamiD· 2 shared

Activity by Year

2020-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenetics

Aroon Dinesh HingoraniORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cross-platform proteomics to advance genetic prioritisation strategies

Maik Pietzner, Eleanor Wheeler, Julia Carrasco-Zanini, Nicola D. Kerrison, Erin Oerton, Mine Koprulu, Jian’an Luan, Aroon Dinesh Hingorani, Steve A. Williams, Nicholas J. Wareham, Claudia Langenberg

The paper compares pQTLs across two proteomic platforms, finding shared and platform-specific pQTLs and identifying factors contributing to platform differences.

bioRxiv · Mar 18, 2021 · PreprintGenetics

Genetic architecture of host proteins interacting with SARS-CoV-2

Maik Pietzner, Eleanor Wheeler, Julia Carrasco-Zanini, Johannes Raffler, Nicola D. Kerrison, Erin Oerton, Victoria P.W. Auyeung, Jian’an Luan, Chris Finan, Juan Pablo Casas, Rachel M. Ostroff, Steve A. Williams, Gabi Kastenmüller, Markus Ralser, Eric R. Gamazon, , Claudia Langenberg

The paper integrates genomic and proteomic data to identify genetic variants influencing host proteins interacting with SARS-CoV-2, revealing potential drug targets and disease mechanisms.

bioRxiv · Jul 1, 2020 · PreprintGenomics